Evidence map›Paper›PMID 26148883›Full record

ArticleIn vitro cellular & developmental biology. Animal2015

Induction of human umbilical Wharton's jelly-derived mesenchymal stem cells toward motor neuron-like cells.

Zohreh Bagher, Somayeh Ebrahimi-Barough, Mahmoud Azami, Hamid Mirzadeh, Mansooreh Soleimani, Jafar Ai, Mohammad Reza Nourani, Mohammad Taghi Joghataei

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Zohreh BagherDepartment of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Somayeh Ebrahimi-BaroughDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mahmoud AzamiDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hamid MirzadehPolymer Engineering Faculty, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.
Mansooreh SoleimaniDepartment of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Jafar AiDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza NouraniTissue Engineering Division, Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mohammad Taghi JoghataeiDepartment of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran. joghataei.mt@iums.ac.ir.
Iran University of Medical Sciences · IRTehran University of Medical Sciences · IRAmirkabir University of Technology · IRBiotechnology Research Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most important property of stem cells from different sources is the capacity to differentiate into various cells and tissue types. However, problems including contamination, normal karyotype, and ethical issues cause many limitations in obtaining and using these cells from different sources. The cells in Wharton's jelly region of umbilical cord represent a pool source of primitive cells with properties of mesenchymal stem cells (MSCs). The aim of this study was to determine the potential of human Wharton's jelly-derived mesenchymal stem cells (WJMSCs) for differentiation to motor neuron cells. WJMSCs were induced to differentiate into motor neuron-like cells by using different signaling molecules and neurotrophic factors in vitro. Differentiated neurons were then characterized for expression of motor neuron markers including nestin, PAX6, NF-H, Islet 1, HB9, and choline acetyl transferase (ChAT) by quantitative reverse transcription PCR and immunocytochemistry. Our results showed that differentiated WJMSCs could significantly express motor neuron biomarkers in RNA and protein levels 15 d post induction. These results suggested that WJMSCs can differentiate to motor neuron-like cells and might provide a potential source in cell therapy for neurodegenerative disease.

Indexed as

AdipocytesBiomarkersCell DifferentiationCells, CulturedEye ProteinsGene Expression RegulationHomeodomain ProteinsHumansLIM-Homeodomain ProteinsMesenchymal Stem CellsMotor NeuronsNestinNeurofilament ProteinsPaired Box Transcription FactorsPAX6 Transcription FactorRepressor ProteinsBiomarkersEye ProteinsHomeodomain Proteinsinsulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsNES protein, humanNestinneurofilament protein HNeurofilament ProteinsPaired Box Transcription FactorsPAX6 protein, humanPAX6 Transcription FactorRepressor ProteinsTranscription FactorsDifferentiationHuman umbilical Wharton’s jelly-derived MSCSMotor neuron

Identifiers

PMID26148883
OpenAlexW2234864836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.